Showing results (11-20 of 85) with videos related to
Sort By:
Pageof 9
Transplantation and Cellular Therapy|May 20, 2026
High incidence of cytomegalovirus infection in patients receiving standard of care CD19- or BCMA-targeted CAR T-cell therapies for hematologic malignanciesTamer Othman, John H Baird, Yan Wang, et al.Cancer Medicine|December 18, 2021
Filanesib plus bortezomib and dexamethasone in relapsed/refractory t(11;14) and 1q21 gain multiple myelomaDarren Pan, Jonathan L Kaufman, Myo Htut, et al.Transplantation and Cellular Therapy|June 13, 2024
Clonal Hematopoiesis is Associated With Severe Cytokine Release Syndrome in Patients Treated With Chimeric Antigen Receptor T-Cell (CART) TherapyScott R Goldsmith, Geoffrey Shouse, F Lennie Wong, et al.Clinical Lymphoma, Myeloma & Leukemia|June 10, 2023
Results of a Phase II Trial of Allogeneic Hematopoietic Stem Cell Transplantation Using 90Y-Ibritumomab Tiuxetan (Zevalin) in Combination With Fludarabine and Melphalan in Patients With High-Risk B-Cell Non-Hodgkin's LymphomaMatthew Mei, Joycelynne Palmer, Nicole Ni-Chun Tsai, et al.Clinical Practice and Cases in Emergency Medicine|November 5, 2025
Orbital Compartment Syndrome as a Complication of Blepharoplasty: A Case ReportLev Libet, Jairo Garcia, Lawrence LiuClinical Lymphoma, Myeloma & Leukemia|September 16, 2023
Ciltacabtagene Autoleucel in Patients With Prior Allogeneic Stem Cell Transplant in the CARTITUDE-1 StudyMyo Htut, Binod Dhakal, Adam D Cohen, et al.Cancer|July 20, 2016
A phase 1 dose-escalation study of filanesib plus bortezomib and dexamethasone in patients with recurrent/refractory multiple myelomaAjai Chari, Myo Htut, Jeffrey A Zonder, et al.Leukemia|February 22, 2020
Phase I/II trial of the oral regimen ixazomib, pomalidomide, and dexamethasone in relapsed/refractory multiple myelomaAmrita Krishnan, Prashant Kapoor, Joycelynne M Palmer, et al.Current Opinion in Oncology|July 26, 2022
Selinexor therapy for multiple myeloma and non-Hodgkin lymphomasScott R Goldsmith, Lawrence Liu, Kevin ShiahPageof 9